JoelMTopfMD

PubMed

• Remove the "Strict" From "Restriction": A #NephJC Editorial on SODIUM-HF.
  Sheikh B Khalid, Rachel Hung, William Andres Vasquez Espinosa, Nayan Arora, Joel M Topf, Jamie Willows> ;Kidney Medicine. 2023 Apr 1
• A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology.
  James A McCormick, Joel Topf, Isabelle Dominique Tomacruz, P Richard Grimm> ;Advances in Kidney Disease and Health. 2023 Mar 1
• User-generated social media content in knowledge dissemination.
  Divya Bajpai, Jamie K Willows, Joel M Topf, Swapnil Hiremath> ;Kidney International. 2022 Dec 1
• 1 citations
  Protein Restriction for CKD: Time to Move On.
  Waseem Obeid, Swapnil Hiremath, Joel M Topf> ;Kidney360. 2022 Sep 29
• 6 citations
  Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.
  Joel Topf, Thomas Wooldridge, Kieran McCafferty, Michael Schömig, Botond Csiky, Rafal Zwiech, Warren Wen, Sarbani Bhaduri, Catherine Munera, Rong Lin, Alia Jebara, Jos...> ;Kidney Medicine. 2022 Aug 1
• Potassium-Enriched Salt to Lower Stroke Risk: A #NephJC Editorial on the SSaSS Study.
  Yoshinosuke Shimamura, Michael Turk, Md Abdul Qader, Shweta Shah, Joel M Topf, Swapnil Hiremath> ;Kidney Medicine. 2022 Jul 1
• 1 citations
  Balanced Solutions Versus Saline to Reduce AKI: A #NephJC Editorial on the BaSICS Trial.
  Mythri Shankar, Carlo Trinidad, Elliot Koranteng Tannor, Swapnil Hiremath, Joel M Topf> ;Kidney Medicine. 2022 Jun 1
• Lanthanum in Dialysis, the LANDMARK Trial: A #NephJC Editorial.
  Carlo Nemesio B Trinidad, Melisha G Hanna, Sharanya Ramesh, Joel M Topf, Swapnil Hiremath> ;Kidney Medicine. 2022 Feb 1
• 1 citations
  Voclosporin for Lupus Nephritis: A #NephJC Editorial on AURORA
  Bourne L. Auguste, Jade Teakell, Avinash Rao Ullur, Joel M. Topf, Swapnil Hiremath> ;Kidney Medicine. 2021 Oct 22
• CONFIRMing Hepatorenal Syndrome Management: #NephJC Editorial
  Jamie Willows, Alicja Rydzewska-Rosołowska, Joel M. Topf, Swapnil Hiremath> ;Kidney Medicine. 2021 Aug 19
• 9 citations
  Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review.
  Vaishali Kapila, Joel M. Topf> ;Cureus. 2021 Aug 11
• 69 citations
  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.
  Edward J. Carr, Andreas Kronbichler, Matthew P M Graham-Brown, Graham Abra, Christos Argyropoulos, Lorraine Harper, Edgar V. Lerma, Rita S. Suri, Joel M. Topf, Michell...> ;Kidney International Reports. 2021 Jul 6
• Facebook Groups Can Provide Support for Patients with Rare Diseases and Reveal Truths About the Secret Lives of Patients.
  Anna Gaddy, Joel M. Topf> ;Kidney International Reports. 2021 Apr 1
• Eight Years of AJKD Blog—Lessons Learned and What Lies Ahead
  Timothy Yau, Matthew A. Sparks, Joel M. Topf> ;American Journal of Kidney Diseases. 2021 Mar 18
• 19 citations
  COVID-19, Social Media, and the Role of the Public Physician.
  Joel M. Topf, Paul Williams> ;Blood Purification. 2021 Jan 14
• 32 citations
  A Picture Is Worth a Thousand Views: A Triple Crossover Trial of Visual Abstracts to Examine Their Impact on Research Dissemination
  Sandra Oska, Edgar V. Lerma, Joel M. Topf> ;Journal of Medical Internet Research. 2020 Dec 4
• 22 citations
  Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Progress or Problems With Peer Review?
  Caitlyn Vlasschaert, Joel M. Topf, Swapnil Hiremath> ;Advances in Chronic Kidney Disease. 2020 Sep 1
• 1 citations
  Introduction: Social Media and Medical Education Come of Age.
  Joel M. Topf> ;Seminars in Nephrology. 2020 May 1
• 24 citations
  Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
  Bishoy Abraham, Michael Megaly, Mina Sous, Mina Fransawyalkomos, Marwan Saad, Robert Fraser, Joel Topf, Steven R. Goldsmith, Mengistu Simegn, Bradley A. Bart, Zain Azz...> ;The American Journal of Cardiology. 2020 Jan 1
• Annals On Call - Chronic Kidney Disease for the Internist
  Robert M. Centor, Joel M. Topf> ;Annals of Internal Medicine. 2019 Jul 16
• 4 citations
  Got CKD? There's an App for That!
  Joel M. Topf, Swapnil Hiremath> ;Clinical Journal of the American Society of Nephrology. 2019 Apr 5
• 18 citations
  Mentorship in the Digital Age: Nephrology Social Media Collective Internship.
  Silvi Shah, Joel M. Topf> ;Clinical Journal of the American Society of Nephrology. 2019 Jan 15
• Annals On Call - Diuretic Resistance
  Robert M. Centor, Joel M. Topf> ;Annals of Internal Medicine. 2018 Oct 16
• 57 citations
  The Social Media Revolution in Nephrology Education
  Gates B. Colbert, Joel M. Topf, Kenar D. Jhaveri, Thomas Oates, Michelle N. Rheault, Silvi Shah, Swapnil Hiremath, Matthew A. Sparks> ;Kidney International Reports. 2018 Feb 17
• 17 citations
  NephMadness After 5 Years: A Recap and Game Plan for the Future
  Matthew A. Sparks, Joel M. Topf> ;American Journal of Kidney Diseases. 2018 Mar 1
• Join now to see all

Journal Articles

• Social media, medicine and the modern journal club  
  Topf J, Hiremath S, Int Rev Psychiatry, 1/1/2015
• Ten Steps for Setting Up an Online Journal Club  
  Chan TM, Thoma B, Radecki R, Topf J, Woo HH, Kao LS, Cochran A, Hiremath S, Lin M, J Contin Educ Health Prof, 1/1/2015
• NephMadness 2015: Nephrology as a Cornerstone of Medicine  
  Sparks MA, Lerma EV, Kupin W, Phelan PJ, Jhaveri KD, Topf J, Am J Kidney Dis, 1/1/2015
• The state of the blog: the first year of eAJKD  
  Desai T, Sparks MA, Nair V, Sethi SK, Topf J, Calderon K, Bury E, Jhaveri KD, Am J Kidney Dis, 1/1/2013
• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis  
  EVOLVE Trial Investigators, Chertow GM, et al, N Engl J Med, 1/1/2012
• CERA: third generation erythropoiesis-stimulating agent  
  Topf JM, Expert Opin. Pharmacother, 1/1/2008
• Nephrogenic fibrosing dermopathy  
  Dungal A, Lattupalli R, Topf J, The Scientific World Journal, 1/1/2008
• Prevalence of proteinuria and the development of chronic kidney disease in HIV infected patients  
  Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP, Clin Nephrol, 1/1/2004
• Prevalence of proteinuria and the development of chronic kidney disease in HIV infected patients.  
  Gupta SK, Mamlin BW, Johnson CS, Dollins MD, Topf JM, Dube MP, Clin Nephrol; 61: 1-6
• Join now to see all

Books/Book Chapters

• Chronic Kidney Disease and Hypertension 
  Chapter: Blood Pressure Vaccines 
  Page 91.0 - 100.0Phisitkul S, Topf, JMEditors: M. Weir, E. Lerma.Humana Press, New York, NY2015
• Michigan Hypertension Core Curriculum 
  Chapter: Lifestyle Modifications 
  Topf JMNational Kidney Foundation of Michigan and Michigan Department of Community Health2010
• Intensive Care Nephrology 
  Chapter: Disorders of potassium homeostasis 
  Page 363.0 - 382.0Topf JM, Asplin JREditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom2006
• Intensive Care Nephrology 
  Chapter: Disorders of calcium, phosphorous, and magnesium 
  Page 383.0 - 412.0Topf JM, Worcester EEditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom2006
• Principles of Critical Care 
  Chapter: Electrolyte disorders in critical care 
  Page 1117. - 1133.Topf JM, Rankin S, Murray PTEditors: Hall JB, Schmidt GA, Wood LDH.McGraw-Hill Professional, United States2005
• The Fluid, Electrolyte and Acid-Base Companion 
  Faubel S, Topf JMAlert and Oriented Publishing, La Jolla, California1999
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, La Jolla, CaliforniaEdition 2nd,1998
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, Ann Arbor, MichiganEdition 2nd,1994
• The Microbiology Companion 
  Topf JM, Faubel SAlert and Oriented Publishing, Ann Arbor, Michigan1993
• The Fluid, Electrolyte and Acid-Base Companion. 
  Faubel S, Topf JMAlert and Oriented Publishing, La Jolla California
• The Microbiology Companion. 
  Topf JM, Faubel SAlert and Oriented Publishing, La Jolla CaliforniaEdition 2nd,
• Intensive Care Nephrology. 
  Chapter: Disorders of potassium homeostasis 
  Page 363 - 382Topf JM, Asplin JREditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom
• Intensive Care Nephrology. 
  Chapter: Disorders of calcium, phosphorous, and magnesium 
  Page 383 - 412Topf JM, Worcester EEditors: Murray PT, Brady HR, Hall JB.Taylor & Francis, United Kingdom
• Principles of Critical Care. 
  Chapter: Electrolyte disorders in critical care 
  Page 1117 - 1133Topf JM, Rankin S, Murray PTEditors: Hall JB, Schmidt GA, Wood LDH.McGraw-Hill Professional, United States
• Join now to see all

Abstracts/Posters

• Correction Rate of Severe Hypernatremia and Morbidity and Mortality in Hospitalized Patients
  Abdulrazzak A, El-Kateb M, Melidonian M, Henderson HL, Topf J, ASN Kidney Week, 1/1/2014
• NephMadness 2014, a Social Media Campaign to Promote Nephrology Education and Interest
  Topf J, Sparks MA, Lerma EV, Kupin WL, Jhaveri KD, ASN Kidney Week, 1/1/2014
• Nephrology Blogosphere: An Analysis of Productivity, Longevity, and Consistency
  Topf JM, ASN Kidney Week, 1/1/2013
• Key Characteristics of Current Social Media Policies at U.S. Allopathic Medical Schools
  Xi A, Topf J, Med 2.0’13 Conference, London, England, 1/1/2013
• The Utility of Fractional Excretion of Sodium and Urea in Advanced Chronic Kidney Disease
  Noureldeen T, Topf JM, ASN Renal Week, 1/1/2011
• Resistant Hypertension: A CKD Clinic Intervention Program To Improve Patient Care
  Pandey AK, Steigerwalt SP, Szpunar SM, Topf JM, Bellovich KA, Provenzano R, ASN Kidney Week, 1/1/2010
• Predictors of Outcome in the Elderly Patients with Chronic Kidney Disease (CKD)
  Marin M, Ishaq RT, Diaz AB Topf JM, ASN Kidney Week, 1/1/2010
• First Year Dialysis Mortality in Patients Previously Enrolled in a Structured Chronic Kidney Disease (CKD) Program
  Topf JM, Provenzano R, Wilson R, Choksi AJ, Bogan A, Amer J Kidney Dis, 1/1/2009
• Predictors of Progressive Versus Stable Chronic Kidney Disease
  Abud G, Topf JM, Provenzano R, J Amer Soc Nephrol, 1/1/2008
• Nephrogenic Fibrosing Dermopathy (NFD): Case Series of 3 Patients in a Single Center
  Lattupalli R, Dhungel A, Bellovich K, Provenzano R, Topf JM, Amer J Kidney Dis, 1/1/2008
• Nephrogenic Fibrosing Dermopathy (NFD) in a Patient with Acute Kidney Injury (AKI)
  Dhungel A, Lattupalli R, El Ghoroury M, Provenzano R, Topf JM, Amer J Kidney Dis, 1/1/2008
• Steroid Resistant Minimal Change Disease Associated With Thymoma: A Case Report
  Lattupalli R, Khairullah Q, Bellovich K, Topf JM, Amer J Kidney Dis, 1/1/2008
• Aldosterone antagonists (AA) are associated with achieved target blood pressure in chronic kidney disease (CKD)
  Topf JM, Steigerwalt S, Provenzano R, American Society of Hypertension, New York, NY, 1/1/2006
• CKD (chronic kidney disease) clinics improve anemia, lipids and arrest the decline of GFR
  Topf JM, Abud G, Provenzano R, J Amer Soc Nephrol, 1/1/2006
• Use of aldosterone antagonists (AA) are associated with achieved blood pressure (BP) control in chronic kidney disease (CKD)
  Topf JM, Steigerwalt S, Provenzano R, J Amer Soc Nephrol, 1/1/2006
• Hyperkalemia in a chronic kidney disease clinic: frequency, risk factors and protective agents
  Topf JM, Alumit G, J Amer Soc Nephrol, 1/1/2006
• The Prevalence of Antiphospholipid Antibodies (APA) in LATE Chronic Kidney Disease (CKD) and incidence following initiation of dialysis
  Topf JM, Shahab H, Mantena S, Nagrecha N, J Amer Soc Nephrol, 1/1/2006
• Cyanide toxicity from nitroprusside in a patient with chronic kidney disease
  Venugopal A, Topf JM, Amer J Kidney Dis, 1/1/2006
• Blood pressure (BP) control by race, gender and chronic kidney disease (CKD) stage in a CKD clinic
  Topf JM, Steigerwalt S, Provenzano R, Amer J Kidney Dis, 1/1/2006
• Lactic acidosis cannot be used to explain an osmolal gap in patients with potential ethylene glycol toxicity. A case report and review of the literature
  Topf JM, Jayakar S, Amer J Kidney Dis, 1/1/2006
• Minimal change disease with incidental mesangial IgA deposits preceding Hodgkin’s lymphoma
  Jefic D, Topf JM, Amer J Kidney Dis, 1/1/2006
• The Prevalence of Antiphospholipid Antibodies (APL) in Chronic Kidney Disease (CKD)
  Nagrecha N, Mantena S, Topf JM, J Amer Soc Nephrol, 1/1/2005
• Anemia Outcomes from a Medical-Assistant Driven Anemia Protocol To Treat Patients and Move Toward Monthly Epoetin Dosing
  Topf JM, Rehman I, Abud, G Maria V, Provenzano R, J Amer Soc Nephrol, 1/1/2005
• The Utility of Fractional Excretion of Sodium and Urea in Advanced Chronic Kidney Disease.
  Noureldeen T, Topf JM, Abstract Renal Week, Philadelphia, USA
• Called Into Question: Using a telephone survey to inquiry into prevelance of Nephrogenic Fibrosing Dermopathy (NFD).
  Lattupalli, R Bellovich, K, Chase P, Provenzano R, Dhungel A, Steigerwalt S, Topf JM, Szpunar S, Amer J Kidney Dis;15(2) p206
• Join now to see all

Lectures

• How to Dip Your Toes into Social Media 
  Montreal, Canada - 1/1/2015
• A Nephrologists guide to getting started in social media 
  Philadelphia, PA - 1/1/2014
• NephMadness: Social Media Campaign to Promote Nephrology Education and Interest 
  Atlanta, GA - 1/1/2013
• Uric Acid and the connection to hypertension and CKD 
  1/1/2013
• Prescribe an App 
  London, England - 1/1/2013
• What is Excellent Supportive Care in Patients with Acute Kidney Injury? How Can I do a Radiologic Study Without Harming My Patient 
  Denver, CO - 1/1/2010
• Use of Handheld Computers in Pediatrics 
  Chicago, IL - 1/1/2004
• Join now to see all

Other

• Acute Renal Failure: Finally, Some Progress 
  Topf JM, Renal & Urology News
  1/1/2006
• Autosomal recessive polycystic kidney disease 
  Topf JM
  UPCMD.com
  1/1/2000
• Autosomal dominant polycystic kidney disease 
  Topf JM
  UPCMD.com
  1/1/2000
• iOS application for pediatricians. Interactive database of age-based normals. 
  Topf JM, Mamlin BW
  http://www.kidometer.com
• Join now to see all